LMR Partners’s Cardiol Therapeutics CRDL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRDL
MI
LMR Partners's CRDL Position: Q3 2026 in Review
LMR Partners opened a new position in Cardiol Therapeutics (CRDL) in Q3 2026: 20,000 shares worth $33.2K. The stake represents ﹤0.01% of the portfolio and ranks #1517 among its holdings.
59 funds tracked by Wall St. Rank hold CRDL as of Q3 2026.
- LMR Partners held 20,000 shares of Cardiol Therapeutics worth $33.2K as of Q3 2026.
- Cardiol Therapeutics was a new LMR Partners position in Q3 2026.
- Cardiol Therapeutics made up ﹤0.01% of LMR Partners's portfolio in Q3 2026, its #1517 holding.
- 59 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q3 2026.
Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.